McGuire Investment Group LLC reduced its stake in Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Free Report) by 2.6% in the fourth quarter, HoldingsChannel.com reports. The fund owned 4,513 shares of the company’s stock after selling 120 shares during the quarter. McGuire Investment Group LLC’s holdings in Direxion Daily S&P Biotech Bull 3x Shares were worth $406,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. SG Americas Securities LLC boosted its position in shares of Direxion Daily S&P Biotech Bull 3x Shares by 6.0% during the fourth quarter. SG Americas Securities LLC now owns 3,392 shares of the company’s stock worth $305,000 after buying an additional 193 shares during the period. Thurston Springer Miller Herd & Titak Inc. acquired a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares during the third quarter worth approximately $43,000. Dunhill Financial LLC acquired a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares during the third quarter worth approximately $46,000. Foundations Investment Advisors LLC boosted its position in shares of Direxion Daily S&P Biotech Bull 3x Shares by 13.0% during the third quarter. Foundations Investment Advisors LLC now owns 4,617 shares of the company’s stock worth $594,000 after buying an additional 530 shares during the period. Finally, Traynor Capital Management Inc. boosted its position in shares of Direxion Daily S&P Biotech Bull 3x Shares by 6.7% during the third quarter. Traynor Capital Management Inc. now owns 10,763 shares of the company’s stock worth $1,386,000 after buying an additional 674 shares during the period.
Direxion Daily S&P Biotech Bull 3x Shares Price Performance
Shares of NYSEARCA:LABU opened at $95.33 on Friday. Direxion Daily S&P Biotech Bull 3x Shares has a 12 month low of $78.46 and a 12 month high of $176.99. The stock’s 50 day moving average price is $101.77 and its 200 day moving average price is $120.39.
Direxion Daily S&P Biotech Bull 3x Shares Profile
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
See Also
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3x Shares
- What is an Earnings Surprise?
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- NYSE Stocks Give Investors a Variety of Quality OptionsĀ
- 3 Buy-and-Hold Stocks for Long-Term Growth
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Despite Short-Term Risks Freeport McMoran Worth a Look
Want to see what other hedge funds are holding LABU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Free Report).
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.